Semaglutide Treatment Dosing Schedule

Last reviewed: May 2026 — Dr. Bismah Irfan, MD

As of May 2026, the standard semaglutide dosing schedule is a 16-week dose-escalation that starts at 0.25 mg once weekly and steps up every four weeks to a maintenance dose of either 1.0 mg (Ozempic, type 2 diabetes), 2.0 mg (Ozempic, intensified diabetes control), or 2.4 mg (Wegovy, chronic weight management). The week-by-week schedule below covers the FDA-approved subcutaneous protocol for both indications.

Semaglutide is a once-weekly GLP-1 receptor agonist, FDA-approved as Ozempic (type 2 diabetes), Wegovy (chronic weight management), and Rybelsus (oral, type 2 diabetes). Dosing differs by indication and by formulation. This guide covers the standard subcutaneous escalation, the differences between diabetes and weight-loss dosing, what to do about missed doses, and the most common questions Houston patients bring up in clinic.

Week-by-Week Semaglutide Escalation Schedule

The 0.25 mg starting dose is sub-therapeutic — it exists to acclimate your GI tract, not to deliver weight loss or glucose control. Each four-week step gives your body time to adjust before the next increase. If you tolerate a step poorly (nausea, vomiting, persistent fatigue), staying at the current dose for an extra cycle is standard practice and does not compromise the eventual response.

For Ozempic in type 2 diabetes, most patients stop at the 1.0 mg maintenance dose; some advance to 2.0 mg if HbA1c targets aren’t met. Wegovy patients continue through the full ladder to 2.4 mg. Compounded semaglutide (where lawfully dispensed) typically follows the Wegovy schedule.

Diabetes vs Weight Loss: Why Dosing Differs

Same molecule, different ceiling. The escalation reflects what the FDA reviewed in each pivotal trial.

• Ozempic (type 2 diabetes) — FDA-approved maintenance doses: 0.5 mg, 1.0 mg, and 2.0 mg once weekly. Glycemic control improves through 1.0 mg in most patients; 2.0 mg is reserved for intensification when HbA1c remains above target.
• Wegovy (chronic weight management) — FDA-approved maintenance dose: 2.4 mg once weekly. Weight-loss efficacy in the STEP trials was strongest at the highest dose, so the label authorizes the full ladder up to 2.4 mg.
• Rybelsus (oral, type 2 diabetes) — 3 mg daily for 30 days, then 7 mg daily; if more control is needed after another 30 days, 14 mg daily. Oral semaglutide is not approved for weight management.

A patient who has both diabetes and obesity may be eligible for either pathway — the choice usually comes down to insurance coverage and which clinical priority the prescribing physician is treating first.

Why a Step-Up Schedule? The Side-Effect Context

The four-week step-up is not arbitrary. Semaglutide’s gastrointestinal side effects — nausea, vomiting, diarrhea, constipation, reflux — are dose-dependent and front-loaded into the first week or two after each increase. If you jumped straight to 1.0 mg from zero, the GI burden would be severe enough that most patients would discontinue. Stepping up gradually lets the gut adapt: nausea at 0.5 mg fades by week 6-7, then a brief recurrence at 1.0 mg fades by week 11, and so on.

Practical implications:

• Take semaglutide on the same day each week. The injection is once-weekly, any day, any time of day. Consistency helps you recognize side-effect patterns.
• Eat smaller, slower meals starting the day before each dose escalation, and continue for 3-5 days after. The first dose at a new level is when nausea peaks.
• If side effects are intolerable at the next step, drop back to the previous dose for another 4 weeks and re-attempt the escalation. This is a normal, expected adjustment — it does not represent treatment failure.
• Persistent vomiting, severe abdominal pain (especially radiating to the back), or signs of dehydration warrant a call to your prescriber, not just a dose pause.

What to Do About a Missed Dose

The practical rules:

• Missed within 5 days — take the dose as soon as you remember, then resume your usual weekly schedule.
• Missed by more than 5 days — skip the missed dose. Take your next dose on the regularly scheduled day. Never double up to make up for a missed dose.
• Missed two or more consecutive doses — call your prescriber before resuming. After a gap of two weeks or longer, many clinicians restart at a lower dose (often the prior step) and re-titrate, because GI tolerance fades quickly during a pause.
• Changing your dosing day — allowed any time, as long as at least 48 hours have passed since the last injection. Many patients drift their dose to Saturday or Sunday over the first few months so the predictable Day-1 nausea lands on a non-working day.

Renal and Hepatic Considerations

Semaglutide does not require dose adjustment for impaired kidney or liver function in current FDA labeling. There is no specific dialysis protocol; semaglutide is not removed by hemodialysis. That said, patients with severe gastroparesis, active pancreatitis history, or recent bariatric surgery should discuss whether semaglutide is appropriate at all — those are clinical contraindications independent of dose.

Storage and Handling Notes

• Refrigerate unopened pens and vials at 2-8°C (36-46°F). Do not freeze. A frozen pen must be discarded.
• An opened, in-use Ozempic or Wegovy pen can stay at room temperature (up to 30°C / 86°F) for up to 56 days. After that, discard regardless of remaining contents.
• Compounded semaglutide (where lawfully dispensed) follows the 28-day in-use stability window from the compounding pharmacy. Reconstituted vials with bacteriostatic water — our step-by-step guide covers the ratio and the swirl-not-shake rule: how much bacteriostatic water to mix with 5 mg of semaglutide.
• Rotate injection sites — abdomen, thigh, or upper arm. Same site repeatedly causes lipohypertrophy and erratic absorption.

Frequently Asked Questions

What is the standard semaglutide dosing schedule for weight loss?
Standard titration is 0.25 mg weekly for the first 4 weeks, then 0.5 mg for weeks 5–8, then 1.0 mg for weeks 9–12, then 1.7 mg for weeks 13–16, and finally 2.4 mg as the maintenance dose from week 17 onward. Each step lasts roughly 4 weeks, and the full schedule reaches maintenance around 16–20 weeks. Slower escalation is common when GI side effects appear.

What if I miss a dose of semaglutide?
If you remember within 5 days of the missed injection, take it as soon as possible and resume your usual weekly schedule. If more than 5 days have passed, skip the missed dose and inject on your next regular day. Never inject two doses to make up for a missed one — doubling raises the risk of nausea, vomiting, and dehydration.

What should I do if weight loss plateaus on semaglutide?
Plateaus are common around month 6–9. First steps: confirm you are at the highest tolerated maintenance dose (often 2.4 mg), audit protein intake (target 1.2–1.6 g/kg body weight), add resistance training 2–3 sessions weekly, and review sleep. If a true plateau persists at maximum dose for 8+ weeks, your clinician may consider switching to tirzepatide or adding an adjunct such as naltrexone-bupropion.

Can I take semaglutide with food, and does meal timing matter?
Subcutaneous semaglutide (Wegovy, Ozempic) is injected weekly and does not require food timing. The oral form (Rybelsus) does — it must be taken on an empty stomach with no more than 4 oz of water, 30 minutes before any food, drink, or other medication. Meal timing only matters for the oral form.

What is the maximum recommended dose of semaglutide?
For weight management, the maximum approved dose is 2.4 mg weekly (Wegovy). For type 2 diabetes, the maximum is 2.0 mg weekly (Ozempic). Doses above these thresholds do not provide additional weight-loss benefit in trials and significantly increase nausea, vomiting, and pancreatitis risk.

What about retatrutide — is it available as an alternative?
Not in 2026. Retatrutide is still in Phase 3 trials. Current FDA status and expected timeline here.

The Bottom Line

Semaglutide’s effectiveness rests on getting the escalation right — slow enough that GI side effects stay manageable, complete enough that you reach a therapeutic dose. The 16-week ladder above is the FDA-recognized template; in practice, every patient’s path looks slightly different. At iVitality MD in Houston, Dr. Bismah Irfan reviews each patient’s tolerance, comorbidities, and weight or glucose trajectory at every titration step, and adjusts the pace as needed.

This article is for educational purposes and is not a substitute for individualized medical advice. Dosing decisions should always be made in consultation with your prescribing physician.